Arovella Therapeutics Limited (ASX:ALA)
0.1050
+0.0070 (7.14%)
Aug 1, 2025, 4:10 PM AEST
United States Steel Market Cap
Arovella Therapeutics has a market cap or net worth of 124.80 million as of August 1, 2025. Its market cap has decreased by -15.15% in one year.
Market Cap
124.80M
Enterprise Value
113.05M
Revenue
3.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 124.80M, an increase of 606.08%. That is a compound annual growth rate of 8.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 124.80M | -30.70% |
Dec 31, 2024 | 180.10M | 72.28% |
Dec 29, 2023 | 104.54M | 574.83% |
Dec 30, 2022 | 15.49M | -17.41% |
Dec 31, 2021 | 18.76M | 22.25% |
Dec 31, 2020 | 15.34M | 85.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 127.86B |
Pro Medicus | 32.80B |
Cochlear | 20.43B |
Sonic Healthcare | 13.51B |
Ramsay Health Care | 8.74B |
Telix Pharmaceuticals | 6.82B |
Ansell | 4.35B |
Mesoblast | 3.01B |